Popular obesity treatment can restore cancer-killing cells.
Posted by giorgiobertin on May 11, 2023
The Kathleen Lonsdale Institute for Human Health Research at Maynooth University just released groundbreaking research on the benefits of the popular obesity treatment drug, GLP-1.
Previous research has found that people with obesity are at a higher risk of developing cancer, in part due to the fact that their cancer-fighting immune cell — better known as a cell “Natural Killer (NK)” – was rendered unusable due to their illness.
The Maynooth University team found that the popular and gold standard drug treatment for obesity, the glucagon-like peptide (GLP-1), can actually restore NK cell function in the body, including its ability to kill cancer cells. The publication was made in the magazine “Obesity“.
“My team and I are very excited about these new findings in relation to the effects of GLP-1 treatment on people with obesity and it appears to have real tangible benefits for those currently taking the drug.“. – says the prof. Andrew E. Hogan.
Read the full text of the article:
Glucagon‐like peptide‐1 therapy in people with obesity restores natural killer cell metabolism and effector function.
Cliona O’Donnell, Ferrah Shaamile, Kiva Brennan, Donal O’Shea, Andrew E. Hogan
Obesity. 2023:ob.23772. doi: 10.1002/ob.23772
Fonte: Il Kathleen Lonsdale Institute for Human Health Research – Maynooth University
This entry was posted on Maggio 11, 2023 a 7:32 am and is filed under News-ricerca.
Contrassegnato da tag: endocrinologia, farmacologia, immunologia, oncologia. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, oppure trackback from your own site.